Treatment

September 28, 2021

Exciting Treatment Developments for Psoriatic Disease

Episode 144

Listen to this exciting update about the biggest treatment developments for biologics, oral agents and topicals for psoriasis and psoriatic arthritis. Leading dermatologist Dr. Andrew Blauvelt, President of Oregon Medical Research Center in Portland shares clinical results, pathways, and why he's excited about such developments!

This activity is supported by unrestricted educational grants from Amgen, Bristol Myers Squibb, Janssen and Novartis. 

Share
Related Items

Stay in the Know.

Expert tips, can’t-miss events and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity Navigator

Copyright © 1996-2021 National Psoriasis Foundation/USA


Duplication, rebroadcast, republication or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.